First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors

Clinical trial NCT03681951 · TERMINATED

Trial details

NCT number: NCT03681951
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Pancreatic

Start date: 2018-11-16
Primary completion: 2019-08-13
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.